1. Home
  2. CENX vs BLCO Comparison

CENX vs BLCO Comparison

Compare CENX & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Aluminum Company

CENX

Century Aluminum Company

HOLD

Current Price

$61.19

Market Cap

6.1B

Sector

Industrials

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$15.08

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CENX
BLCO
Founded
1995
1853
Country
United States
Canada
Employees
N/A
13000
Industry
Aluminum
Ophthalmic Goods
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1B
5.4B
IPO Year
2004
2022

Fundamental Metrics

Financial Performance
Metric
CENX
BLCO
Price
$61.19
$15.08
Analyst Decision
Strong Buy
Buy
Analyst Count
3
11
Target Price
$65.67
$18.45
AVG Volume (30 Days)
1.7M
412.2K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.23
N/A
Revenue
$1,893,200,000.00
$5,101,000,000.00
Revenue This Year
$20.77
$8.65
Revenue Next Year
$14.58
$5.59
P/E Ratio
$18.87
N/A
Revenue Growth
N/A
6.47
52 Week Low
$16.64
$11.44
52 Week High
$70.43
$18.92

Technical Indicators

Market Signals
Indicator
CENX
BLCO
Relative Strength Index (RSI) 47.83 40.13
Support Level $55.59 $14.55
Resistance Level $68.15 $15.57
Average True Range (ATR) 3.85 0.38
MACD -0.65 -0.02
Stochastic Oscillator 22.59 24.58

Price Performance

Historical Comparison
CENX
BLCO

About CENX Century Aluminum Company

Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. The company produces high purity aluminum, standard-grade aluminum sow and tee bars, and value-added billet and foundry products. The company also owns a carbon anode production facility in the Netherlands.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: